免疫检查点抑制剂治疗晚期非小细胞肺癌后的挽救性手术：免疫相关不良事件与更长生存期之间的潜在关联 - Suppr

Salvage Surgery After Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: Potential Association Between Immune-Related Adverse Events and Longer Survival.

作者信息

Nagata Shunichi, Hamaji Masatsugu, Ozasa Hiroaki, Yamada Yoshito, Ohsumi Akihiro, Date Hiroshi

机构信息

Department of Thoracic Surgery, Nagara Medical Center, Gifu, Japan; Department of Thoracic Surgery, Kyoto University, Kyoto, Japan.

Department of Thoracic Surgery, Kyoto University, Kyoto, Japan.

出版信息

Clin Lung Cancer. 2022 Jul;23(5):e321-e324. doi: 10.1016/j.cllc.2022.05.002. Epub 2022 May 11.

DOI:10.1016/j.cllc.2022.05.002

PMID:35649818

Abstract

摘要

相似文献

Salvage Surgery After Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: Potential Association Between Immune-Related Adverse Events and Longer Survival.

Clin Lung Cancer. 2022 Jul;23(5):e321-e324. doi: 10.1016/j.cllc.2022.05.002. Epub 2022 May 11.

Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy.

Eur J Cancer. 2021 Mar;145:221-229. doi: 10.1016/j.ejca.2020.10.017. Epub 2021 Jan 27.

Nivolumab-associated Stevens-Johnson syndrome in a patient with lung cancer.

Dermatol Online J. 2021 Mar 15;27(3):13030/qt2897t6dq.

Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy.

Adv Ther. 2020 Jul;37(7):3178-3184. doi: 10.1007/s12325-020-01386-y. Epub 2020 May 20.

Impact of concomitant medication on clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.

Thorac Cancer. 2021 Jul;12(13):1983-1994. doi: 10.1111/1759-7714.14001. Epub 2021 May 14.

Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer.

Clin Transl Oncol. 2021 Mar;23(3):582-590. doi: 10.1007/s12094-020-02452-1. Epub 2020 Jul 13.

Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy.

Respir Med. 2019 Jan;146:66-70. doi: 10.1016/j.rmed.2018.11.021. Epub 2018 Dec 13.

Association of immune-related pneumonitis with clinical benefit of anti-programmed cell death-1 monotherapy in advanced non-small cell lung cancer.

Cancer Med. 2021 Jul;10(14):4796-4804. doi: 10.1002/cam4.4045. Epub 2021 Jun 13.

Nivolumab-induced fulminant type 1 diabetes with precipitous fall in C-peptide level.

J Diabetes Investig. 2020 May;11(3):748-749. doi: 10.1111/jdi.13143. Epub 2019 Oct 6.

Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.

Clin Lung Cancer. 2019 May;20(3):201-207. doi: 10.1016/j.cllc.2018.10.002. Epub 2018 Oct 11.

引用本文的文献

Good responses to first-line immunotherapy-included treatment in lung squamous carcinoma with rare driver gene mutations: a report of three cases.

Transl Lung Cancer Res. 2025 Jun 30;14(6):2337-2346. doi: 10.21037/tlcr-2025-469. Epub 2025 Jun 26.

Characteristics and outcomes of salvage surgery after immune checkpoint inhibitor therapy for initially unresectable non-small cell lung cancer.

J Thorac Dis. 2024 Sep 30;16(9):6094-6100. doi: 10.21037/jtd-24-891. Epub 2024 Sep 24.

Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery.

Surg Today. 2024 Oct;54(10):1146-1153. doi: 10.1007/s00595-024-02811-3. Epub 2024 Mar 14.

Salvage pleurectomy/decortication following immunotherapy for malignant pleural mesothelioma.

Interdiscip Cardiovasc Thorac Surg. 2024 Feb 2;38(2). doi: 10.1093/icvts/ivad173.

Treatment of induced oligometastatic disease after partial response to immunochemotherapy in patient with stage IV non-small cell lung cancer and severe toxicity.

BMJ Case Rep. 2022 Dec 14;15(12):e252590. doi: 10.1136/bcr-2022-252590.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Salvage Surgery After Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: Potential Association Between Immune-Related Adverse Events and Longer Survival.

作者信息

Nagata Shunichi, Hamaji Masatsugu, Ozasa Hiroaki, Yamada Yoshito, Ohsumi Akihiro, Date Hiroshi

机构信息

Department of Thoracic Surgery, Nagara Medical Center, Gifu, Japan; Department of Thoracic Surgery, Kyoto University, Kyoto, Japan.

Department of Thoracic Surgery, Kyoto University, Kyoto, Japan.

出版信息

Clin Lung Cancer. 2022 Jul;23(5):e321-e324. doi: 10.1016/j.cllc.2022.05.002. Epub 2022 May 11.

DOI:10.1016/j.cllc.2022.05.002

PMID:35649818

Abstract

摘要

相似文献

Salvage Surgery After Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: Potential Association Between Immune-Related Adverse Events and Longer Survival.

Clin Lung Cancer. 2022 Jul;23(5):e321-e324. doi: 10.1016/j.cllc.2022.05.002. Epub 2022 May 11.

Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy.

Eur J Cancer. 2021 Mar;145:221-229. doi: 10.1016/j.ejca.2020.10.017. Epub 2021 Jan 27.

Nivolumab-associated Stevens-Johnson syndrome in a patient with lung cancer.

Dermatol Online J. 2021 Mar 15;27(3):13030/qt2897t6dq.

Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy.

Adv Ther. 2020 Jul;37(7):3178-3184. doi: 10.1007/s12325-020-01386-y. Epub 2020 May 20.

Impact of concomitant medication on clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.

Thorac Cancer. 2021 Jul;12(13):1983-1994. doi: 10.1111/1759-7714.14001. Epub 2021 May 14.

Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer.

Clin Transl Oncol. 2021 Mar;23(3):582-590. doi: 10.1007/s12094-020-02452-1. Epub 2020 Jul 13.

Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy.

Respir Med. 2019 Jan;146:66-70. doi: 10.1016/j.rmed.2018.11.021. Epub 2018 Dec 13.

Association of immune-related pneumonitis with clinical benefit of anti-programmed cell death-1 monotherapy in advanced non-small cell lung cancer.

Cancer Med. 2021 Jul;10(14):4796-4804. doi: 10.1002/cam4.4045. Epub 2021 Jun 13.

Nivolumab-induced fulminant type 1 diabetes with precipitous fall in C-peptide level.

J Diabetes Investig. 2020 May;11(3):748-749. doi: 10.1111/jdi.13143. Epub 2019 Oct 6.

Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.

Clin Lung Cancer. 2019 May;20(3):201-207. doi: 10.1016/j.cllc.2018.10.002. Epub 2018 Oct 11.

引用本文的文献

Good responses to first-line immunotherapy-included treatment in lung squamous carcinoma with rare driver gene mutations: a report of three cases.

Transl Lung Cancer Res. 2025 Jun 30;14(6):2337-2346. doi: 10.21037/tlcr-2025-469. Epub 2025 Jun 26.

Characteristics and outcomes of salvage surgery after immune checkpoint inhibitor therapy for initially unresectable non-small cell lung cancer.

J Thorac Dis. 2024 Sep 30;16(9):6094-6100. doi: 10.21037/jtd-24-891. Epub 2024 Sep 24.

Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery.

Surg Today. 2024 Oct;54(10):1146-1153. doi: 10.1007/s00595-024-02811-3. Epub 2024 Mar 14.

Salvage pleurectomy/decortication following immunotherapy for malignant pleural mesothelioma.

Interdiscip Cardiovasc Thorac Surg. 2024 Feb 2;38(2). doi: 10.1093/icvts/ivad173.

Treatment of induced oligometastatic disease after partial response to immunochemotherapy in patient with stage IV non-small cell lung cancer and severe toxicity.

BMJ Case Rep. 2022 Dec 14;15(12):e252590. doi: 10.1136/bcr-2022-252590.

Salvage Surgery After Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: Potential Association Between Immune-Related Adverse Events and Longer Survival.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Salvage Surgery After Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: Potential Association Between Immune-Related Adverse Events and Longer Survival.

作者信息

机构信息

出版信息

相似文献

引用本文的文献